Cargando…

Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry()

INTRODUCTION: Patients with COVID-19 and cardiovascular disease risk factors (CVDRF) have been reported to develop coagulation abnormalities frequently. However, there are limitations in conventional predictive models for the occurrence of thromboembolism in patients with COVID-19 and CVDRF. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shibahashi, Eiji, Jujo, Kentaro, Kuroda, Shunsuke, Matsumoto, Shingo, Sano, Takahide, Kitai, Takeshi, Yonetsu, Taishi, Kohsaka, Shun, Torii, Sho, Yamaguchi, Tetsuo, Kishi, Takuya, Komuro, Issei, Hirata, Kenichi, Node, Koichi, Matsue, Yuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232261/ https://www.ncbi.nlm.nih.gov/pubmed/35777328 http://dx.doi.org/10.1016/j.thromres.2022.06.007

Ejemplares similares

External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors
por: Kuroda, Shunsuke, et al.
Publicado: (2021)

Impact of body mass index on the outcome of Japanese patients with cardiovascular diseases and/or risk factors hospitalized with COVID-19 infection
por: Saito, Takafumi, et al.
Publicado: (2022)

Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors
por: Higaki, Akinori, et al.
Publicado: (2022)

Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors　― Insights From a Nationwide Japanese Cohort Study ―
por: Yoshida, Naofumi, et al.
Publicado: (2021)

Impact of serum lactate dehydrogenase on the short-term prognosis of COVID-19 with pre-existing cardiovascular diseases
por: Masumoto, Akiko, et al.
Publicado: (2022)

Sex Differences in Clinical Outcomes Among Patients With COVID-19 and Cardiovascular Disease　― Insights From the CLAVIS-COVID Registry ―
por: Matsumoto, Shingo, et al.
Publicado: (2022)

Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients
por: Kitakata, Hiroki, et al.
Publicado: (2021)

D-dimer and Beyond: Harnessing the Potential of New Coagulation Indicators in COVID-19 Management
por: Shibahashi, Eiji, et al.
Publicado: (2023)

Histological examination of the right atrial appendage after failed catheter ablation for focal atrial tachycardia complicated by cardiogenic shock in a post-partum patient
por: Mizukami, Akira, et al.
Publicado: (2016)

Clinical Outcome and Diverse Risk Factors for Different Therapeutic Target Locations of Peripheral Artery Disease
por: Ko, Toshiyuki, et al.
Publicado: (2020)

Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19)　― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―
por: Mizuno, Atsushi, et al.
Publicado: (2021)

Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failure
por: Jujo, Kentaro, et al.
Publicado: (2017)

9‐Year Trend in the Management of Acute Heart Failure in Japan: A Report From the National Consortium of Acute Heart Failure Registries
por: Shiraishi, Yasuyuki, et al.
Publicado: (2018)

Impact of brain natriuretic peptide reduction on the worsening renal function in patients with acute heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2020)

Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2022)

Derivation and Validation of Clinical Prediction Models for Rapid Risk Stratification for Time-Sensitive Management for Acute Heart Failure
por: Shiraishi, Yasuyuki, et al.
Publicado: (2020)

Characteristics and in-hospital outcomes of patients undergoing balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a time-trend analysis from the Japanese nationwide registry
por: Minatsuki, Shun, et al.
Publicado: (2021)

Joint Declaration on COVID-19 by the Japan Stroke and Japanese Circulation Societies
por: Kishi, Takuya, et al.
Publicado: (2020)

Effectiveness of methotrexate as a second-line treatment for cardiac sarcoidosis assessed via (18)F-FDG PET: a case report
por: Dotare, Taishi, et al.
Publicado: (2022)

Potential Role of Twitter at an Annual Congress in Japan　― Narrative Literature Review of “Tweet the Meeting” ―
por: Mizuno, Atsushi, et al.
Publicado: (2019)

Effect of the COVID-19 Pandemic on Acute Respiratory Care of Hypoxemic Patients With Acute Heart Failure in Japan　― A Cross-Sectional Study ―
por: Matsue, Yuya, et al.
Publicado: (2020)

Verification of Optimal Balloon Size in Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
por: Minatsuki, Shun, et al.
Publicado: (2023)

Advances in Intravascular Imaging: New Insights into the Vulnerable Plaque from Imaging Studies
por: Yonetsu, Taishi, et al.
Publicado: (2017)

One‐year estimated glomerular filtration rate decline as a risk factor of cardiovascular and renal end‐points in high‐risk Japanese patients
por: Meguro, Shu, et al.
Publicado: (2020)

Coronary spasm and optical coherence tomography defined plaque erosion causing ST-segment-elevation acute myocardial infarction in a patient with COVID-19 pneumonia
por: Nakao, Masahiko, et al.
Publicado: (2020)

Pentraxin3 in Chronic Thromboembolic Pulmonary Hypertension: A New Biomarker for Screening from Remitted Pulmonary Thromboembolism
por: Naito, Akira, et al.
Publicado: (2014)

Different Contributions of Physical Activity on Arterial Stiffness between Diabetics and Non-Diabetics
por: Iwasa, Takeshi, et al.
Publicado: (2016)

Impact of psychiatric disorders on the hemodynamic and quality of life outcome of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a retrospective study
por: Hirose, Kazutoshi, et al.
Publicado: (2023)

Cardiology Department Practices in the First Wave of the Coronavirus Disease Pandemic　― A Nationwide Survey in Japan by the Japanese Circulation Society―
por: Mizuno, Atsushi, et al.
Publicado: (2021)

Biodegradable Extremely-Small-Diameter Vascular Graft Made of Silk Fibroin can be Implanted in Mice
por: Tanaka, Kimie, et al.
Publicado: (2020)

Association of visit‐to‐visit glycemic variability with risk of cardiovascular diseases in high‐risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial
por: Sato, Midori, et al.
Publicado: (2021)

Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer‐VTE Registry)
por: Ikeda, Masataka, et al.
Publicado: (2022)

Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights from REALITY-AHF
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

Venous thromboembolism and cancer risk
por: Sandén, Per, et al.
Publicado: (2016)

Coronary Embolization Caused by Pleomorphic Lung Carcinoma
por: Murai, Tadashi, et al.
Publicado: (2016)

Myocardial Infarction Potentially Caused by Erosion and Spasm
por: Horie, Tomoki, et al.
Publicado: (2018)

Decreasing skeletal muscle as a risk factor for mortality in elderly patients with sepsis: a retrospective cohort study
por: Shibahashi, Keita, et al.
Publicado: (2017)

Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma
por: Kondo, Shunsuke, et al.
Publicado: (2018)

Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure
por: Maeda, Daichi, et al.
Publicado: (2021)

The Prognostic Value of B‐Type Natriuretic Peptide in Patients With Cardiac Sarcoidosis Without Heart Failure: Insights From ILLUMINATE‐CS
por: Miyakuni, Shota, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7383ii1jjdlt30kpp8q2p9idhg